Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.923%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 52.00
GCL Live PriceLast checked at -
Geiger Counter is an Investment Trust

To deliver attractive returns to shareholders principally in the form of capital growth, through investment in companies involved in the exploration, development and production of uranium to supply the nuclear power industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of outstanding Subscription Share Rights

6 May 2022 12:25

RNS Number : 6455K
Geiger Counter Ltd
06 May 2022
 

6 May 2022

GEIGER COUNTER LIMITED(THE "COMPANY")

 

Exercise of outstanding Subscription Share Rights

Geiger Counter Limited announces that further to the announcement on 5 May 2022, the Subscription Trustee has exercised all of the 4,474,044 outstanding Subscription Rights (the "Rump"). The ordinary shares of no par value in the capital of the Company ("Ordinary Shares") that arose from the exercise of the Rump have been sold by finnCap Limited by way of a secondary market placing, raising total net proceeds for the Company of £1.69 million. After deduction of the cost of exercising the Subscription Rights of the Rump and all the costs and expenses of the Subscription Trustee, the Registrar and the secondary market placing, any resultant net proceeds will be distributed by the Registrar to the holders of the Rump in proportion to their Shareholding on the Record Date by 31 May 2022.

Following the exercise of all Subscription Rights, the Company has raised a total of £6.73 million resulting in the net assets of the Company now exceeding £70 million. The funds raised will be invested in a manner consistent with the stated investment objectives of the Company.

Accordingly, the Company announces that it will be issuing and allotting a further 4,474,044 Ordinary Shares, pertaining to the outstanding Subscription Rights exercised by the Subscription Trustee, subject to admission to trading. Application will be made for the new Ordinary Shares to be admitted to trading on TISE and dealings on LSE SETSqx. It is expected that dealings in the new Ordinary Shares will commence at 8.00 a.m. on 10 May 2022.

Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), following Admission the issued ordinary share capital of the Company will consist of 133,853,153 Ordinary Shares with voting rights attached. The Company does not hold any shares in treasury. This figure of 133,853,153 Ordinary Shares may be used by the Company's shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the DTRs.

 

The information contained within this RNS is considered to be inside information prior to its release.

For further information, please contact:

CQS (UK) LLP

Craig Cleland

 

+44 (0) 20 7201 5368

finnCap Limited

William Marle / Milesh Hindocha - Corporate Finance

 

+44 (0) 20 7220 0500

Mark Whitfeld / Pauline Tribe - Sales

+44 (0) 20 7220 0500

R&H Fund Services (Jersey) Limited

Jane De Barros-Sousa

+44 (0) 1534 825 259

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGGKMVDGZZM
Date   Source Headline
15th Dec 20231:00 pmRNSNet Asset Value(s)
14th Dec 20231:50 pmRNSNet Asset Value(s)
13th Dec 20231:40 pmRNSNet Asset Value(s)
12th Dec 20232:15 pmRNSReplacement: Net Asset Value(s)
12th Dec 20231:00 pmRNSNet Asset Value(s)
11th Dec 20231:45 pmRNSNet Asset Value(s)
8th Dec 20233:10 pmRNSNet Asset Value(s)
7th Dec 20235:15 pmRNSNet Asset Value(s)
6th Dec 20234:05 pmRNSNet Asset Value(s)
5th Dec 20231:05 pmRNSNet Asset Value(s)
5th Dec 202312:45 pmRNSReplacement: Net Asset Value(s)
4th Dec 20232:45 pmRNSNet Asset Value(s)
4th Dec 202310:15 amRNSShare Buyback
1st Dec 20232:55 pmRNSNet Asset Value(s)
1st Dec 202310:59 amRNSAnnual Overview from QuotedData
1st Dec 202310:30 amRNSShare Buyback
30th Nov 202312:45 pmRNSNet Asset Value(s)
30th Nov 202312:15 pmRNSShare Buyback
29th Nov 20232:15 pmRNSNet Asset Value(s)
29th Nov 202310:45 amRNSShare Buyback
28th Nov 20234:40 pmRNSNet Asset Value(s)
27th Nov 20233:15 pmRNSNet Asset Value(s)
24th Nov 202312:10 pmRNSNet Asset Value(s)
24th Nov 20239:30 amRNSMonthly Investor Report
23rd Nov 20233:10 pmRNSNet Asset Value(s)
22nd Nov 20231:15 pmRNSNet Asset Value(s)
21st Nov 20231:00 pmRNSNet Asset Value(s)
20th Nov 20232:30 pmRNSNet Asset Value(s)
17th Nov 20232:15 pmRNSNet Asset Value(s)
16th Nov 20233:00 pmRNSNet Asset Value(s)
15th Nov 20235:15 pmRNSInvestment Manager Acquisition
15th Nov 20232:40 pmRNSNet Asset Value(s)
14th Nov 202311:50 amRNSNet Asset Value(s)
13th Nov 202312:40 pmRNSNet Asset Value(s)
10th Nov 20232:40 pmRNSNet Asset Value(s)
9th Nov 202312:15 pmRNSNet Asset Value(s)
8th Nov 20232:25 pmRNSNet Asset Value(s)
7th Nov 20231:10 pmRNSNet Asset Value(s)
6th Nov 20233:10 pmRNSNet Asset Value(s)
3rd Nov 20233:40 pmRNSNet Asset Value(s)
2nd Nov 20234:00 pmRNSNet Asset Value(s)
1st Nov 20231:35 pmRNSNet Asset Value(s)
31st Oct 20232:30 pmRNSNet Asset Value(s)
30th Oct 20231:00 pmRNSNet Asset Value(s)
27th Oct 20232:55 pmRNSNet Asset Value(s)
26th Oct 202312:45 pmRNSNet Asset Value(s)
25th Oct 20234:45 pmRNSNet Asset Value(s)
24th Oct 20232:35 pmRNSNet Asset Value(s)
23rd Oct 20234:45 pmRNSNet Asset Value(s)
23rd Oct 20232:15 pmRNSShare Buyback

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.